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Immunodeficiency and lymphoid malignancy are hallmarks of the human disease Nijmegen breakage
syndrome (NBS; OMIM 251260), which is caused by NBS1 mutations. Although NBS1 has been shown to bind
to the T-cell receptor alpha (TCR) locus, its role in TCR rearrangement is unclear. Hypomorphic mutations
of Nbs1 in mice and patients result in relatively mild T-cell deficiencies, raising the question of whether the
truncated Nbs1 protein might have clouded a certain function of NBS1 in T-cell development. Here we show
that the deletion of the entire Nbs1 protein in T-cell precursors (Nbs1T-del) results in severe lymphopenia and
a hindrance to the double-negative 3 (DN3)-to-DN4 transition in early T-cell development, due to abnormal
TCR coding and signal joints as well as the functions of Nbs1 in T-cell expansion. Chromatin immunopre-
cipitation (ChIP) analysis of the TCR loci reveals that Nbs1 depletion compromises the loading of Mre11/
Rad50 to V(D)J-generated DNA double-strand breaks (DSBs) and thereby affects resection of DNA termini and
chromatin conformation of the postcleavage complex. Although a p53 deficiency relieves the DN33DN4
transition block, neither a p53 deficiency nor ectopic expression of TCR rescues the major T-cell loss in
Nbs1T-del mice. All together, these results demonstrate that Nbs1’s functions in both repair of V(D)J-generated
DSBs and proliferation are essential for T-cell development.
DNA double-strand breaks (DSBs) are generated by exog-
enous DNA damage stimuli (e.g., ionizing radiation) and en-
dogenous metabolic intermediates, such as collapsed replica-
tion forks. Upon DSB generation, NBS1 together with MRE11
and RAD50 form the MRN complex (26). MRE11, which
contains two DNA binding domains, mediates the MRN com-
plex binding to the exposed DNA ends. The adjacent MRN-
associated DNA ends could be further tethered together
through the coiled-coil domain (zinc hook) of RAD50 (19, 43).
The chromatin loading of MRN stimulates the ATM kinase
that subsequently phosphorylates the downstream effectors,
such as p53 and CHK2, for cell cycle regulation, apoptosis, and
repair initiation (9, 27, 40). In addition to transducing the
repair signal, the NBS1/MRN complex participates in modu-
lating DNA damage response (DDR) pathways by promoting
error-free homology-directed repair (HDR) while repressing
nonhomologous end joining (NHEJ) to minimize the genera-
tion of errant, therefore potentially “dangerous,” DNA joints
in S- and G2/M-phase cells (47).
Mutations in any of the MRN complex proteins increase
genomic instability and cause human genomic instability dis-
orders. NBS1 hypomorphism causes the autosomal recessive
disorder Nijmegen breakage syndrome (NBS; OMIM 251260).
NBS patients show multisystemic defects, among which immu-
nodeficiency and a predisposition to lymphoid malignancies
originating from B- or T-cell lineages are the major hallmarks
(11, 22). NBS patients are prone to opportunistic infections
due to agammaglobulinemia, primarily IgA and IgG. Other
immune defects include a reduced total number of CD3 and
CD4 but not CD8 single-positive (SP) T cells (11, 22, 30).
The MRN complex is therefore proposed to play an important
role in the sensing (as a DDR component) and repairing (as a
component of NHEJ) of V(D)J-generated DSBs and thereby
to have its regulatory function in lymphoid development (2,
13). However, NBS patient cells carrying hypomorphic muta-
tions of the NBS1 gene fail to demonstrate a direct role of
NBS1 in V(D)J recombination (15, 20, 48).
During lymphocyte development, G1-phase-specific endo-
nucleases RAG1/2 generate the DSBs at recombination signal
sequences (RSS) flanking functional V, D, and J gene seg-
ments, which are in turn joined mainly by the NHEJ machinery
(13, 28). Recent studies using intrachromosomal recombina-
tion substrates in the MRN hypomorphic mouse B cells or a
small interfering RNA (siRNA) knockdown of MRN in cell
lines demonstrate that the MRN complex stabilizes the DSB
ends generated by RAG1/2 to promote canonical NHEJ (C-
NHEJ; LigIV-Xrcc4 dependent) and also alternative NHEJ
(A-NHEJ; LigIV-Xrcc4 independent) if C-NHEJ is not avail-
able (8, 10, 12, 17, 32, 34, 44, 46).
NBS1 consists of multiple domains and interacts with several
key DDR molecules at both the early or late stages of the DDR
cascade (49). While hypomorphic mutation supports cell and
mouse survival, the complete loss of any of the MRN compo-
nents causes embryonic lethality, suggesting a vital role of Nbs1
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in viability and proliferation. Hypomorphic Nbs1 mice show a
T-lymphoid defect, characterized by a specific reduction of
CD4 CD8 double-positive (DP) and CD4 single-positive
(SP) T-cell populations but a rather normal amount of CD8
SP and CD4 CD8 double-negative (DN) T cells (17, 23).
During T-cell development, Nbs1 localizes to the T-cell recep-
tor alpha (TCR) locus (7), and unjoined TCR coding ends
are accumulated in the hypomorphic Nbs1 murine T cells (17).
Collectively, these findings indicate that Nbs1/the MRN com-
plex may function in V(D)J recombination during the late
stage of T-cell development by specifically affecting the TCR
locus rearrangement (17). Given the essential function of
NBS1, or MRN, in sensing and repairing DSBs, cell cycle
control, and cell viability, full-length NBS1 may be expected to
have a strong impact on lymphoid development. Current work-
ing models depicting that Nbs1 is involved in the repair of
DSBs during V(D)J recombination have been developed from
cells containing truncated Nbs1 isoforms (for example, p72),
which may mask additional functions of NBS1. In the present
study, we engineer mice with an Nbs1-specific deletion in early
developing thymocytes and explore the additional function of
the entire NBS1 protein in T-cell development, which might
have not been seen previously in an Nbs1 hypomorphic back-
ground.
MATERIALS AND METHODS
Generation of Nbs1T-del, Nbs1T-del p53/, and Nbs1F/F Lck-Cre Rag2/
AND mice. Nbs1F6/F6 mice (14) were crossed with Lck-Cre mice (kindly pro-
vided by Christopher Wilson, University of Washington, Seattle, WA), giving rise
to Nbs1F6/F6 Lck-Cre mice, i.e., Nbs1T-del mice (mice with deletion of the entire
Nbs1 protein in the T cells). Additionally, Nbs1T-del mice were crossed with p53
knockout mice to generate Nbs1T-del p53/ mice. In addition, Nbs1T-del mice
were crossed with Rag2/ AND mice (kindly provided by Andre´ Nussenzweig,
NIH) to generate mice with the genotype Nbs1F6/F6 Lck-Cre Rag2/ AND
(Nbs1T-del Rag2/ AND) (24, 36). All animals were maintained under specific-
pathogen-free conditions at the animal facility of the Leibniz Institute for Age
Research-Fritz Lipmann Institute (FLI), Jena, Germany. Animal care and ex-
periments were performed in accordance with the ethic committee guidelines.
For PCR genotyping, the following two primers were used to identify the Nbs1F6
allele (1.2 kb) and the Nbs1-deleted () allele (0.6 kb): loxPtestR, AATACAG
TGACTCCTGGAGG, and Intron5F, ATAAGACAGTCACCACTGCG. For a
specific genotyping of the different stages of DN cells, the additional primer,
EX6, CAGGGCGACATGAAAGAAAAC, together with the above-mentioned
primers, was used to identify the Nbs1F6 allele (0.3 kb) and the Nbs1-deleted ()
allele (0.6 kb). The p53 knockout allele can be detected by PCR using the
following primers: X7, TATACTCAGAGCCGGCCT; X6.5, ACAGCGTGGT
GGTACCTTAT; and Neo, CATTCAGGACATAGCGTTGG. To genotype the
Rag2 knockout allele, we used 3f, GCAAGGACGCTCTAGGAATG, and 3r,
TAGTCCCGTTTCCCATGTTG. To detect the TCR transgene, the follow-
ing primers were used: TCR-f, GACTTGGAGATTGCCAACCCATATCTA
AGT, and TCR-r, TGAGCCGAAGGTGTAGTCGGAGTTTGCATT.
Flow cytometry analysis. The thymi and spleens were mashed through a 40-m
nylon membrane and then treated with the ACK buffer (0.15 mM NH4Cl, 10 mM
KHCO3, 0.1 mM Na2EDTA [pH 7.2]). The cells were resuspended in cold
phosphate-buffered saline (PBS) containing 2% fetal calf serum (FCS), subjected
to staining with phycoerythrin (PE)-, fluorescein isothiocyanate (FITC)-, allo-
phycocyanin (APC)-, and PE-Cy5-conjugated monoclonal antibodies, and ana-
lyzed with a FACSCanto flow cytometer equipped with FACSDiva software
(Becton Dickinson, Mountain View, CA). The panel of FITC-labeled monoclo-
nal antibodies included CD19 and CD44 (Pharmingen, San Diego, CA). The
PE-conjugated antibodies used were CD25, CD3, and CD4 (Pharmingen). The
APC and PE-Cy5-conjugated antibodies used were CD8 and CD4 (Pharmingen).
Apoptosis was analyzed by staining cells with FITC-conjugated annexin V anti-
body (Pharmingen) in the annexin V staining solution (10 mM HEPES-NaOH at
pH 7.4, 140 mM NaCl, 2.5 mM CaCl2).
Lymphocyte sorting and stimulation. After the T-cell isolation and antibody
staining, the DN, DP, and SP thymocyte subpopulations were purified from
thymi to 95% purity using a FACSAria cell sorter (Becton Dickinson). For in
vitro T-cell stimulation, sorted thymocytes were treated simultaneously with
anti-CD3 and anti-CD28 antibodies (10 g/ml each) or 5 g/ml phytohemagglu-
tinin (PHA; Sigma-Aldrich, Munich, Germany) together with 10 ng/ml phorbol
myristate acetate (PMA; Sigma-Aldrich). Prior to stimulation, lymphocytes were
stained with 2.5 M carboxyfluorescein diacetate succinimidyl ester (CFSE) (29).
The cells were analyzed by flow cytometry at the indicated time.
V(D)J recombination profiling. Genomic DNA was isolated from the sorted
DP, SP, and DN T cells and amplified by PCR using the following primers: for
the  locus coding joint, V13, 5-GAGGAAAGGTGACATTGAGC-3, and
J2.7, 5-TGAGAGCTGTCTCCTACTATCGATT-3; for the  locus signal
joint (5), D1, 5-AGAGGAGCAGCTTATCTGGTGG-3, and V14, 5-CTT
TGGTGACTTCTGACTTGA-3; and for the  locus signal joint (38), SJ56,
5-CAGTAGGGGATGGATGCTAACATGA-3, and ADV8-RS, 5-CCTGCA
CCCTTGGTTCATGTG-3.
The PCR products were gel purified and subsequently cloned into the PCR-
Topo TA vector (Invitrogen, Karlsruhe, Germany). The sequences were com-
pared with those in the UCSC database (http://genome.ucsc.edu/) for a further
characterization of the resolved V(D)J recombination. The raw sequences of the
TCR status are provided in Tables S1 to S4 in the supplemental material.
ChIP assay. Freshly isolated thymocytes (1 	 107) were cross-linked with 1%
formaldehyde, and chromatin immunoprecipitations (ChIPs) were performed as
described previously (18) using 4 g of a polyclonal antibody specific for Rad50
(Upstate, Lake Placid, NY), 
-H2AX (Upstate), or acetyl-histone H4 (Ac-H4;
Upstate). Input DNA and immunoprecipitated DNA were analyzed by PCR for
the presence of V1, V30, V5, and V21 recombination signal sequences
(RSSs). The primers used to amplify the sequences of interest included the
following: V1, 5CTGGGGACAAAGAGGTCAAA3 and 5GGGAAGTCTG
GGTAGGAAGG3; V30, 5TCTGGGGCTACAGCTGATTT3 and 5GCAT
TAGGCATGAGGGAAAA3; V5, 5CTGGGAAGCGTCTTCAGTTC3 and
5AAAAGTGTGCCACTCCATCC3; and V21, 5TTGGTACCGACAGGTT
CCTC3 and 5TGCTGAGCTCATTGCTCACT3. PCR products were resolved
on a 2% agarose gel and stained with ethidium bromide.
Chromosome metaphase preparation and cytogenetic analysis. The thymo-
cytes from 8-week-old control and Nbs1T-del mice were isolated as described
above. Thymocytes (1 	 107 to 5 	 107) were cultured in complete RPMI 1640
medium supplemented with 10% FCS and stimulated with 10 units/ml interleu-
kin-2 (IL-2; Chiron, Ratingen, Germany), 10 ng/ml PMA (Sigma-Aldrich), and
750 ng/ml ionomycin (Sigma-Aldrich) (33). After 48 h of incubation at 37°C, 20
ng/ml colcemid (Sigma-Aldrich) was added, and the metaphases were prepared
according to the standard protocol. For telomere fluorescence in situ hybridiza-
tion (T-FISH), hybridization of FITC-labeled peptide nucleic acid (PNA) telo-
meric probes (Dako, Hamburg, Germany) onto metaphases was conducted by
following the company’s manual. The pictures of metaphase were captured and
analyzed by BandView and FISHView softwares (Applied Spectral Imaging
system) installed on a Zeiss Imager M1 microscope.
Immunoblotting. Proteins extracted from cells in a RIPA buffer (20 mM
HEPES at pH 7.6, 20% glycerol, 0.5 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA at
pH 8.0, 0.5% NP-40, 1 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonyl
fluoride [PMSF], 5 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM -glycerophos-
phate, 1 mM Na3VO4, and 10 mM NaF) were resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), blotted with antibodies
in 1	 Tris-buffered saline–Tween 20 (TBS-T) containing 5% nonfat dried milk,
followed by an incubation with horseradish peroxidase-conjugated secondary
antibodies, and detected by ECL reagents (Amersham Biosciences, Buckingham-
shire, United Kingdom). The following antibodies were used: rabbit anti-Nbs1
antibody (1:1,000; Cell Signaling, Danvers, MA), mouse anti-PARP-1 (1:2,000;
R&D Systems, Wiesbaden-Nordenstadt, Germany), and mouse anti-Chk2 (1:
1,000; Upstate).
Histopathology and immunohistological staining. The tissues used for histo-
logical examination were fixed in 4% buffered formalin and embedded in par-
affin. The sections (5 m) were stained with hematoxylin and eosin (H&E) and
mounted for microscopy. The pictures are processed with AxioVision software.
RESULTS
T-cell-specific deletion of Nbs1 in mice results in central and
peripheral T-cell lymphopenia. To investigate the essential
function of Nbs1 in lymphoid development and V(D)J recom-
bination, we crossed Nbs1F6/F6 mice (14) with Lck-Cre trans-
genic mice, which express Cre recombinase in T-cell precursors
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(DN cells). PCR and Western blot analyses confirmed that
Nbs1F6/F6 Lck-Cre mice had a deletion of Nbs1 specifically
in the thymi and all T-cell populations but not CD19 B
cells (Fig. 1A to D). Hence, we designated Nbs1F6/F6 Lck-
Cre as Nbs1T-del. The control group of mice (Nbs1T-ctr)
includes Nbs1/ Lck-Cre, Nbs1/ Lck-Cre, Nbs1/F6
Lck-Cre, Nbs1/F6 Lck-Cre, and Nbs1F6/F6 Lck-Cre
mice, all of which carried at least one functional Nbs1 allele.
Young Nbs1T-del mice exhibited a marked atrophy of the
medullar compartment in the thymi (Fig. 2A). Flow cytometry
analysis of the thymi and spleens from 4-week-old mice re-
vealed a greatly reduced cellularity and proportion of all dis-
tinct T-cell populations. Whereas the average cellularity of DP
cells was 10 	 107 in Nbs1T-ctr mice, it reached only 4.6 	 107
in Nbs1T-del mice (2-fold reduction) (Fig. 2B). The reduction
of CD4 or CD8 SP thymocytes was even more pronounced,
from 1.1 	 107 CD4 SP cells in Nbs1T-ctr mice to 0.17 	 107
CD4 SP cells in Nbs1T-del mice (6.5-fold reduction) and
from 0.26 	 107 CD8 SP cells in Nbs1T-ctr to 0.03 	 107
CD8 SP cells in Nbs1T-del mice (8.7-fold reduction) (Fig.
2C). The relative frequency and cellularity of CD4 and CD8
SP cells were also reduced in the Nbs1T-del spleen and blood
samples (Fig. 2C and D; also data not shown). Among the
general loss of SP cells, TCR2- and TCR8.3-expressing ma-
ture T cells were greatly reduced (data not shown). In addition,
a considerably high percentage of apoptotic T cells was present
in the thymi and spleens from mutants (Fig. 2E). After in vitro
stimulation with PHA/PMA or TCR cross-linking antibodies
(against CD3/CD28), Nbs1T-del T cells failed to proliferate
(Fig. 3A and C) and showed prominent apoptosis (Fig. 3B and
D), which is similar to the response of NBS patient T cells (42).
All these data demonstrate dramatic defects of T-cell devel-
opment and function when Nbs1 is completely deleted in an
early stage.
Since ATM and NBS1 act in the same pathway upon DSB
generation (27), we further compared the T-cell profile of
Atm/ mice with that of our Nbs1T-del mice (1). Atm/ mice
showed only a mild percentage of CD4 SP reduction but no
reduction of CD8 SP cells compared to those of wild-type
controls (Fig. 2F), which is consistent with previous reports (1,
41). Compared to Atm/ mice, Nbs1T-del mice have signifi-
cantly fewer CD4 and CD8 SP cells in the thymi and also in
the spleens (Fig. 2F). These data seem to indicate that the
functions of ATM and NBS1 in T-cell development are not
identical, despite their biochemical functions in the same DSB
response.
The absence of Nbs1 specifically hampers the DN3-to-DN4
transition in T-cell development. To determine the stage at
which T-lymphocyte development is affected, we investigated
early T-cell development from T-cell precursors. Double stain-
ing with CD25 and CD44 antibodies, which mark the develop-
mental stages before TCR rearrangement, revealed that the
Nbs1T-del thymus contained normal or even slightly higher dou-
ble-negative 1 (DN1; CD44 CD25), DN2 (CD44 CD25),
and DN3 (CD44 CD25) populations (Fig. 4A). However,
the frequency of Nbs1T-del DN4 (CD44 CD25) cells was
significantly decreased (21.2%) compared to that of controls
(34.5%; P  0.029) (Fig. 4A). PCR analysis revealed that the
Nbs1 deletion was readily detectable at the DN1 stage, and the
majority (80%) was deleted at the DN3 stage (Fig. 4B). It
seems that the percentage of DN4 cells (Fig. 4A) in our Nbs1T-del
mice was overrepresented because a high fraction of DN4 cells
(50%) still contained the intact Nbs1 allele (Fig. 4B), which
might be derived from DN3 cells escaping the deletion of the
Nbs1 locus.
Loss of Nbs1 impairs the processing of V(D)J-associated
DSBs in TCR coding joints. The transition from DN3 to DN4
corresponds to the stage of TCR gene rearrangement (16).
To further investigate how Nbs1 contributes to the repair of
DSBs in V(D)J recombination, we analyzed the V(D)J coding
joints of the TCR locus in Nbs1T-del T cells. To this end, we
chose and amplified V13-D1/2-J2.7 recombination prod-
ucts by PCR and sequenced these joints (Fig. 5A; see also
Tables S1 and S2 in the supplemental material). We found that
Nbs1T-del T cells had a significantly higher portion of V(D)J
joints with longer D segments (93% in mutants compared to
73% in controls; here, we used 4 nucleotides [nt] as the thresh-
old to define long or short D1/2 segments) (Fig. 5B and C; see
also Tables S1 and S2 in the supplemental material). Mean-
while, the nucleotide insertion rate in the V13-D1/2 junc-
FIG. 1. The specific deletion of Nbs1 in the T-cell lineage. (A) PCR analysis of the Nbs1 deletion in the thymus (Th) and spleen (Sp) of the
indicated genotype. “Co” and “” represent samples obtained from Nbs1T-ctr and Nbs1T-del mice, respectively. PCR controls used Nbs1F6 (F) and
Nbs1-deleted () alleles. (B) Western blot analysis of the Nbs1 deletion in thymi and spleens of 4-week-old Nbs1T-ctr and Nbs1T-del mice. PARP-1
is used as a loading control. (C) PCR analysis of the Nbs1 deletion in genomic DNA from sorted CD3, B220, and CD4 CD8 populations from
Nbs1T-del thymi and spleens as well as bone marrow (BM) cells. Tail DNA (tail) is used to control the floxed allele. (D) PCR analysis of the Nbs1
deletion in sorted CD19, CD4, CD8, and CD4 CD8 populations from Nbs1T-del thymi and spleens.
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tion region was also significantly increased (63% in controls
versus 84% in mutants; P 0.05) (Fig. 5B and C) and similarly
increased in the D1/2-J2.7 joint, where the nucleotide in-
sertion rate was consistently elevated albeit not statistically
significant (66% in controls versus 77% in mutants; P  0.05).
In addition, for the V13-D1/2-J2.7 coding joint deletion,
we detected less frequently degraded coding ends during
V(D)J recombination, although they cannot reach a statisti-
cally significant level (P  0.05) (Fig. 5B and C). Nevertheless,
as combined consequences of the above-mentioned pheno-
types, the Nbs1T-del T cells had formed longer coding joint
regions than those of controls (6.2 nt in Nbs1T-del versus 3.5 nt
in controls; P  0.05) (Fig. 5D). These findings suggest a
defective DNA end processing or a resection of V(D)J termini
when Nbs1 is completely deleted.
Nbs1 deletion affects the joining of signal joints. To test if a
complete Nbs1 loss also affects signal joint formation, we ex-
amined signal joints for V14-D1 and J56-ADV8 (5, 38). A
sequence analysis of cloned PCR products showed that more
than 55% of the signal regions in both control and Nbs1T-del T
cells had perfect joining (see Tables S3 and S4 in the supple-
mental material), indicating that Nbs1T-del mice have robust
signal joint formation. This is consistent with the previous
report which found that c-Abl-transformed MRN hypomor-
phic B cells have normal signal joint formation (10, 17). How-
ever, in those signal joints with imperfect joining, Nbs1-null T
cells showed a high preference for the usages of the GC nu-
cleotide rather than those of the AT nucleotide. For the 
locus, the GC/AT ratio is 1.03 in Nbs1T-ctr T cells and 3.86 in
Nbs1T-del T cells (P  0.01); for the  locus, the GC/AT ratio
is 1.5 in Nbs1T-ctr T cells and 2.1 in Nbs1T-del T cells (P  0.05)
(Fig. 5E; see also Tables S3 and S4 in the supplemental ma-
terial). These interesting results suggest altered terminal de-
oxynucleotidyltransferase (TdT) activity in the TCR loci in
the absence of Nbs1.
Rag-induced DSB repair and chromatin conformation
around V(D)J segments in Nbs1T-del T cells. MRN helps sta-
bilize the coding joints in the “postcleavage complex,” and the
enzymatic activity of Mre11 can process DSB ends (10, 44).
The abnormalities in V(D)J joints, especially in TCR coding
FIG. 2. Nbs1T-del mice develop central and peripheral T-cell lymphopenia. (A) H&E staining of thymus sections from 4-week-old Nbs1T-ctr and
Nbs1T-del mice. Me, medulla. (B) Numbers of CD4 CD8 DP T cells in the thymi of Nbs1T-ctr and Nbs1T-del mice (n  6; 3 to 5 weeks of age).
(C) Numbers of CD4 and CD8 SP T cells in the thymi and spleens of Nbs1T-del mice are compared to those in the thymi and spleens of Nbs1T-ctr
mice (n  6; 3 to 5 weeks of age). (D) Frequency of CD4 CD8 DP, CD4 SP, and CD8 SP T cells in the thymi and spleens of Nbs1T-del mice
relative to the controls (n 6; 3 to 5 weeks of age). (E) Proportion of annexin V-positive T cells in the thymi and spleens of Nbs1T-ctr and Nbs1T-del
mice. (F) Comparison of lymphopenia in Nbs1T-del and Atm/ mice. The histogram shows the comparison of the average percentages of CD4
and CD8 SP T cells in the thymi and spleens of Nbs1T-ctr, Nbs1T-del, and Atm/ mice (n  4; 3 to 5 weeks of age). Co, Nbs1T-ctr; , Nbs1T-del;
*, P  0.05; **, P  0.01; ***, P  0.001. P values were obtained using Student’s unpaired t test.
VOL. 30, 2010 ESSENTIAL ROLE OF Nbs1 IN T-CELL DEVELOPMENT 5575
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joints of Nbs1T-del T cells, may reflect the Nbs1-null-mediated
DSB repair defect to process coding ends prior to joining. To
gain insight into the impact of the Nbs1-null mutation in V(D)J
end processing and stability, we analyzed the DSB repair status
around Rag-induced DSB sites by chromatin immunoprecipi-
tation (ChIP) (Fig. 6A). We first examined the status of

-H2AX, a DSB marker, in the V(D)J joints in both distal and
proximal V regions of TCR and - loci (V1, V30, V5, and
FIG. 3. Cellular response to T-cell activation in Nbs1T-del mice. (A) Thymocytes were stimulated with anti-CD3/anti-CD28 antibodies and
labeled with CFSE. The proliferation of Nbs1T-ctr and Nbs1T-del CD4 and CD8 SP T cells was analyzed at the indicated time points by flow
cytometry, according to the CFSE dilution. (B) Apoptotic cells after stimulation with anti-CD3/anti-CD28 antibodies were determined by annexin
V staining. (C) Thymocytes were stimulated with PMA/PHA and labeled with CFSE. The proliferation of Nbs1T-ctr and Nbs1T-del CD4 and CD8
SP T cells was analyzed at the indicated time points by flow cytometry, according to the CFSE dilution. (D) Apoptosis after PMA/PHA treatment
was determined by annexin V staining. Co, Nbs1T-ctr; , Nbs1T-del.
FIG. 4. The Nbs1-null mutation affects the transition from the DN3 to DN4 stages in early T-cell development. (A) The histogram shows the
different DN subpopulations in the total DN population, according to their surface markers CD44 and CD25. These data are the mean percentages
for at least 6 mice from each genotype. (B) PCR analysis of the Nbs1 deletion in sorted DN subpopulations, according to their CD44 and CD25
expression profiles. F, Nbs1 floxed allele; , Nbs1-deleted allele. (C) Frequencies of CD4 and CD8 SP T cells obtained from 4-week-old
littermates of Nbs1T-ctr, Nbs1T-del, and Nbs1T-del p53/ mice. These data are the mean percentages for at least three mice from each genotype.
Co, Nbs1T-ctr; , Nbs1T-del; /p53, Nbs1T-del p53/; *, P  0.05; ***, P  0.001. P values were obtained using Student’s unpaired t test.
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V21). We recovered more 
-H2AX products from these re-
gions in the Nbs1-null T cells than in controls, suggesting that
Rag1/2-induced DSBs were persistent, reflecting inefficient re-
pair in Nbs1-null T cells (Fig. 6A). Consistent with this notion,
using the RAD50 antibody, we precipitated fewer products
from Nbs1T-del T-cell extracts than from control cell extracts
(Fig. 6A). This indicates that Rad50 loading to DSBs was
compromised because of the Nbs1 deletion, which in turn
might impair the stability and thereby the processing of the
DSB ends. Since the H2AX phosphorylation-mediated chro-
matin response to DSBs facilitates MRN loading and further
DNA end processing (37), we next monitored the chromatin
status around V(D)J ends using an antibody against acetyl-
histone H4 (Ac-H4), a marker of a relaxed chromatin confor-
mation. Consistent with the 
-H2AX status, we found more
products from V segments in Nbs1T-del thymocytes than from
those in controls, indicating an open chromatin conformation
around these gene segments (Fig. 6A). All together, the initi-
ation of the DSB response in Nbs1T-del T cells seems normal,
as indicated by the presence of 
-H2AX, but the processing of
V(D)J termini is compromised.
The persistence of the 
-H2AX and relaxed chromatin in
Nbs1T-del T cells indicates the defects in the repair process
without Nbs1. We further confirmed the DNA repair defect in
the Nbs1-null T cells by cytogenetic analysis of thymocytes
upon treatment with PMA/IL-2/ionomycin. While the chromo-
some numbers were unchanged in Nbs1T-del T cells, we found
significantly higher frequencies of chromosomal breaks and
fusions in Nbs1T-del T cells than in Nbs1T-ctr T cells (Fig. 6B).
In total, 73% of Nbs1T-del metaphases contained at least one
aberration, in contrast to 53% in the control group (P  0.01)
(Fig. 6B). The defect is most likely mediated by the ATM-
CHK2 pathway rather than the ATR-CHK1 pathway, since
Nbs1T-del T cells show an attenuated ATM-CHK2 pathway
(Fig. 6C) but not an attenuated ATR-CHK1 pathway (data not
shown) after an in vitro challenge of Nbs1T-del T cells with
adriamycin and UV, which is consistent with previous obser-
vations (35).
A p53 deficiency and the TCR transgene cannot fully correct
Nbs1T-del lymphopenia. T-cell lymphopenia in Nbs1T-del mice
could be a combined defect of a Nbs1-mediated repair of DSBs
and of proliferation. The transition from DN3 to DN4 corre-
sponds to the stage of TCR gene rearrangement (16), and the
reduction of DN4 cells in Nbs1T-del mice implies a defective
Nbs1 function in repairing V(D)J-associated DSBs in the
TCR locus, which could trigger the p53-dependent apoptotic
FIG. 5. Nbs1 deletion results in aberrant processing of V(D)J coding ends and signal ends. (A) Scheme for V(D)J recombination in TCR V
13, D1 or D2, and J 2.7 gene loci. Arrowheads indicate primer positions. (B) TCR gene rearrangement analyzed by sequencing the PCR
products of indicated segments in genomic DNA isolated from 4-week-old Nbs1T-ctr and Nbs1T-del thymocytes. n, number of PCR products
analyzed. The original data are shown in Tables S1 and S2 in the supplemental material. (C) PCR sequencing analysis of TCR gene
rearrangements in thymocyte DNA isolated from 4-week-old Nbs1T-ctr and Nbs1T-del mice. The frequency of the V(D)J joints is plotted. (D) Size
of resolved V13-D1/2-J2.7 regions in Nbs1T-ctr and Nbs1T-del mice. (E) Nucleotide usages in V14-D1 and J56-ADV8 signal joints of control
and Nbs1T-del mice (n, number of sequences used for the GC/AT ratio calculation). The P value is calculated using the percentage of GC in
imperfect joints (see Tables S3 and S4 in the supplemental material). Co, Nbs1T-ctr; , Nbs1T-del; *, P  0.05; **, P  0.01; n.s., not significant.
The chi-square test was used for calculations in panels B and C, and the unpaired Student’s t test was used for calculations in panels D and E.
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pathway. In order to test this hypothesis, we crossed Nbs1T-del
mice into a p53-deficient background. A p53 deletion in Nbs1T-del
mice completely restored the DN4 cell population (Fig. 4A),
suggesting that the affected DN3-to-DN4 transition was likely
DNA breaks based and mediated by p53 activation. Although a
p53 deficiency could rescue the DN4 cell loss in Nbs1T-del mice,
the survival advantage given by the p53 loss did not significantly
increase the total number of immature DP and mature SP T cells
in theNbs1T-del thymus and spleen (Fig. 4C). It is possible that the
T-cell lymphopenia in Nbs1T-del mice is caused by the failure of
resolving the V(D)J recombination termini and by the subsequent
membrane-bound death receptor-mediated positive and negative
selection or proliferation defects.
To further examine the contribution of DSBs and TCR
function-mediated T-cell loss in the absence of Nbs1, we
crossed Nbs1T-del mice into the Rag2/ AND genetic back-
ground. Rag2/ AND mice are devoid of endogenous V(D)J
recombination because they lack Rag2-mediated DSBs in
TCRs, but they ectopically express the transgenic TCR re-
ceptor (AND) (24, 36). Nbs1T-del Rag2/ AND mice
reached 26% of the thymic cellularity of Nbs1T-ctr Rag2/
AND controls (Fig. 7A). In addition, the CD4 SP fraction in
Nbs1T-del Rag2/ AND mice was about 51% of that of the
Nbs1T-ctr Rag2/ AND controls (29% in Nbs1T-del Rag2/
AND mice and 57% in Nbs1T-ctr Rag2/ AND mice) (Fig.
7B). Under the condition of Rag2 deficiency, the TCR trans-
gene partially restored the mature CD4 T cells in the Nbs1T-del
mice (51%, in comparison with 30% left in the Rag2/
background) (Fig. 2B and 7B). Despite this increased fre-
quency, the total number of CD4 SP cells was still signifi-
cantly lower in Nbs1T-del Rag2/ AND mice than in controls
(Fig. 7C), arguing for a role of Nbs1 in T-cell proliferation and
viability.
DISCUSSION
A complete deletion of Nbs1 in the T-cell lineage resulted in
a6-fold reduction of CD4 and CD8 SP T cells and a 2-fold
reduction of DP cells. These findings are in contrast with an
approximately 2- to 3-fold reduction of CD4 SP cells and yet
a normal level of CD8 SP cells in human NBS patients for
whom NBS1 is hypomorphic (11, 22, 30). Moreover, hypomor-
phic mutations of Nbs1 in mice resulted in about a 30% re-
duction of SP T cells and DP T cells (17, 23). The mild T-cell
phenotype of hypomorphic NBS1 in humans and mice is likely
attributable to the presence of a truncated NBS1 protein,
which supports survival and possibly proliferation (see below).
Notably, although ATM and NBS1 act in a common DDR
pathway in vitro, compared to our Nbs1T-del mice, Atm-null
thymi show roughly a 25% reduction of the total cellularity but
a normal frequency of CD4 CD8 DP cells and CD8 SP
cells (1, 41) (Fig. 2F).
V(D)J analysis of hypomorphic mutant Nbs1 and Mre11
mice and Atm-null mice reveals very similar V(D)J recombi-
nation defects, particularly in the TCR locus, marked by
unrepaired coding ends (17, 41). It seems that hypomorphic
Nbs1 or Mre11 proteins and full-length Atm play largely over-
lapping roles in V(D)J processing and rather affect the later
stage of T-cell development. In our study, in addition to reca-
pitulating the later defect of TCR locus recombination, as
shown in Atm/ mice and Nbs1/Mre11 hypomorphic mice (17,
21), the deletion of the complete Nbs1 protein in T cells un-
expectedly affects the T-cell development as early as in the
DN3-to-DN4 transition, which has not been reported in hypo-
mophic MRN mutant mice or Atm-null mice. The similar but
discrepant T-cell phenotypes of Atm-null and T-cell-specific
FIG. 6. Defects in V(D)J-initiated DNA repair, chromosome instability, and impaired DDR in Nbs1-deleted T cells. (A) ChIP analysis using
antibodies against Rad50, 
-H2AX, and Ac-H4. These antibodies recovered distal and proximal V (left) and V (right) regions of Nbs1T-ctr and
Nbs1T-del thymocytes. Co, Nbs1T-ctr; , Nbs1T-del; 
-H2AX, phospho-histone H2AX; Ac-H4, acetyl-histone H4. (B) Summary of the chromosomal
stability in Nbs1T-ctr and Nbs1T-del T cells. The metaphases were prepared from 8-week-old Nbs1T-ctr and Nbs1T-del T cells 48 h after IL-2/PMA/
ionomycin stimulation. n, number of metaphases analyzed. **, P  0.01. Student’s unpaired t test was used, except that the chi-square test was
applied for calculation of the percentage of metaphases containing aberrations. (C) Western blot analysis of Nbs1 and Chk2 in whole-cell extracts
from Nbs1T-ctr and Nbs1T-del thymocytes after 2 h of treatment with 0.2 g/ml of adriamycin (Adr). PARP-1 is used as a loading control. The ratio
of the phosphorylated form of Chk2 (upper band) was corrected to that of the nonphosphorylated form (lower band) by ImageJ software and
indicated under the corresponding lanes. NA, not applicable.
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Nbs1-null mice argue that ATM and NBS1 have overlapping,
yet distinct, functions in T-cell lymphogenesis.
Interestingly, the blocking of the DN3-DN4 transition is
coincident with the TCR rearrangement, and the defective
V(D)J recombination may be one of the reasons for the severe
T-cell lymphopenia in Nbs1T-del mice. Nbs1 is required for a
proper coding joint formation because a Nbs1 deletion in par-
ticular lengthened the V(D)J joints in the TCR locus of
Nbs1T-del T cells. The less frequent deletion of the V and J
joint regions and the less degraded D1/2 segments might be
due to inefficient processing of V(D)J joints in the Nbs1T-del
TCR locus by Mre11 (the nuclease component of MRN). The
MRN complex has the capacities of DNA bridging (by Rad50)
and end processing (via the endonuclease and exonuclease
activities of Mre11) (4, 43). The persistent DSBs or the defec-
tive processing of V(D)J coding ends in the Nbs1-null T cells
could be due to a defective recruitment of MRN components
for DNA end tethering and of DNA end resection factors, such
as Mre11, for Rag-generated DSB end processing (44). Con-
sistent with this notion, the binding of Rad50 to the DNA end
coding joints in TCR as well as in the TCR locus was
attenuated in Nbs1-null T cells, thereby compromising the en-
zymatic activity of Mre11 to process the DNA ends. In addi-
tion, the retention of the unrepaired coding joints, suggested
by the persistent 
-H2AX signals and open chromatin struc-
ture, leaves a broad time window for other terminal modifying
enzymes, for example, template-independent TdT, to act on
Rag1/2-generated DNA ends, which may account for longer
coding joints in the TCR locus.
For signal joint formation, which is a direct and fast-joining
process of two blunt DNA ends during V(D)J recombination,
Nbs1T-del T cells efficiently joined signal ends, consistent with
results from other reports (10), suggesting that Nbs1 is dis-
pensable for the joining process. However, it is interesting to
notice that the Nbs1T-del T cells signal joints showed a strong
preference for the GC-nucleotide insertion, which has not
been documented previously in Nbs1 hypomorphic mutant
cells. The mechanism of such a biased use of nucleotides is
unclear at the moment, but it is possible that delayed DNA end
joining may affect the activity (albeit unintentionally) of the
template-independent TdT. Interestingly, the analysis of T
cells of Artemis/ and SCID mice (DNA-PKcs mutated) also
revealed an increased bias of GC/AT composition in the signal
joints (39). The catalytic activity of TdT could be modified
upon binding to DNA-PKcs (31). Previously, the failure of the
hairpin opening caused by DNA-PKcs/Artemis in Atm/ T
cells indicates that ATM may be involved in the recruitment of
DNA-PKcs/Artemis to V(D)J ends (3, 21). It is possible that
the impaired MRN-ATM axis in Nbs1T-del T cells may com-
promise the loading of DNA-PKcs to the DNA ends of signal
joints and thus affect the TdT activity and joint sequence di-
versity.
The severe T-cell lymphopenia in Nbs1T-del mice could also
be attributed to increased apoptosis, which may be caused by
chromosomal instability. A p53 deficiency relieved the block of
DN3-to-DN4 transition and restored the DN4 cell population,
indicating that the transition block is likely to be dependent on
cell death triggered by persistent DNA coding ends generated
during TCRV(D)J recombination (Fig. 6A and B). However,
in contrast to the neural rescue effect of a p53 deficiency on
Nbs1-central nervous system (CNS)-deleted mice (14), the p53
deficiency in Nbs1T-del mice did not restore the total thymic
cellularity, suggesting that an Nbs1 deletion also has an impact
on proliferative expansion in late T-cell development. Since
TCR expression needs only one round of V(D)J recombina-
tion, while TCR locus expression requires at least five rounds
FIG. 7. Rescue experiment of T-cell lymphopenia in Nbs1T-del mice with the TCR transgene (AND) and a Rag2 deficiency. (A) The total
thymus cellularity in Nbs1T-ctr Rag2/ AND (n  2) and Nbs1T-del Rag2/ AND (n  6) mice. (B) Representative T-cell profiles of the
thymocytes obtained from two Nbs1T-ctr Rag2/ AND mice and four age-matched Nbs1T-del Rag2/ AND mice. (C) The total number of CD4
SP cells obtained from thymi of Nbs1T-del mice (n  2) relative to the controls (n  4) in the Rag2/ AND genetic backgrounds. ***, P  0.001
using Student’s unpaired t test.
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of V(D)J recombination, a p53 deficiency might be insufficient
to rescue those DP cells with extensive unrepaired DNA
breaks carrying on during TCR rearrangements (21, 45).
Another reason for p53’s failure to restore the total cellu-
larity is perhaps due to proliferation defects of Nbs1T-del T
cells. TCR transgene expression in Atm/ mice could re-
store up to 80% of the T-cell population (6), suggesting that
the V(D)J defect and TCR selection are the major reasons
for the T-cell loss in Atm/ mice. Interestingly, when we
inhibited the V(D)J-generated DNA breaks by inactivating
Rag2 (36), the TCR transgene partially restored the mature
CD4 T cells in Nbs1T-del mice, which show 51% of controls
(1-fold reduction) (Fig. 7B) compared to 30% of controls
(2-fold reduction) (Fig. 2B) in the Rag2/ background. The
increased Nbs1T-del CD4 SP population in the Rag2/
AND background suggests a role for Nbs1 in the repair of the
V(D)J-induced DSBs and perhaps in the positive and negative
selection processes. However, even if DSBs are prevented by
Rag2 deficiency and TCR is provided to allow a normal
positive and negative selection (in the Rag2/ AND back-
ground), the total CD4 SP numbers as well as thymic cellu-
larity are still very low in Nbs1T-del Rag2/ AND mice (Fig.
7A and C). These observations thus well indicate that the
function of Nbs1 in cell proliferation is likely to be responsible
for the major loss of the T cells in late stages, as suggested
previously in Nbs1-deleted B cells (25, 35). Therefore, the loss
of T cells after Nbs1 deletion is likely through its function in
cell proliferation, viability, and not exclusively, cell death via 
selection because of an aberrant V(D)J recombination.
Taken together, a complete deletion of Nbs1 in early T-cell
precursors affects TCR V(D)J rearrangements and results in
the persistence of Rag1/2-generated coding joint ends due to
their inefficient processing in the absence of Nbs1. In addition,
the Nbs1-null mutation abolishes proliferative expansion dur-
ing positive and negative selection, which cannot be rescued by
p53 deletion or overexpression of the TCR transgene. All
these mark the common but unique function of Nbs1 (MRN)
compared to that of Atm. Thus, the study of T cells devoid of
the entire Nbs1 protein reveals a physiological function of
Nbs1 in repairing the Rag-induced DSBs during TCR recom-
bination and proliferation, and both of which are essential for
T-cell development.
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